Twelve Infants Die During Clinical Trials for FDA-Endorsed RSV Drug – The Vaccine Reaction

Twelve Infants Die During Clinical Trials for FDA-Endorsed RSV Drug – The Vaccine Reaction: On June 8, 2023, the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously (21-0) in favor of AstraZeneca and Sanofi’s new nirsevimab (Beyfortus) monoclonal antibody drug believed to provide protection for infants from respiratory syncytial...